Gastroenterology Research, ISSN 1918-2805 print, 1918-2813 online, Open Access
Article copyright, the authors; Journal compilation copyright, Gastroenterol Res and Elmer Press Inc
Journal website http://www.gastrores.org

Original Article

Volume 11, Number 5, October 2018, pages 355-360


Clinical, Histologic, and Immunophenotypic Features of Serrated Polyps in Patients With Inflammatory Bowel Disease

Tables

Table 1. Characteristics of Inflammatory Bowel Disease Patients With Serrated Lesions (2004 to 2014)
 
FeatureHPSSA/PP value
Pts: patients; y: years.
Number of cases (number of patients)25 (17 pts)11 (11 pts)
Age (y), mean (range)47.8 (29 to 75)55.2 (29 to 68)0.2
Male/female7/106/50.7
IBD type (UC vs. CD)14:118:30.25
Mean IBD duration at index, years (IQR)17.7 (1 to 40)12.7 (3 to 20)0.42
Polyp/flat lesion22/310/11
Right/left colon9/117/40.46

 

Table 2. Staining Pattern for Ki-67 and BRAF for HP and SSA/P
 
Study groupControl group
SSA/PHPSSA/PHP
*Two cases of SSA/P in study group and one HP from the control group were excluded from BRAF evaluation with inadequate tissue for interpretation after BRAF immunostain.
Site
  Left (%)4 (36.4%)15 (60.0%)4 (26.7%)15 (60.0%)
  Right (%)7 (63.6%)10 (40.0%)11 (73.3%)10 (40.0%)
  P value0.681
BRAF*
  Positive (%)5 (55.6%)13 (52.0%)11 (73.3%)13 (54.2%)
  Negative (%)4 (44.4%)12 (48.0%)4 (26.7%)11 (45.8%)
  P value0.411
β-catenin
  Positive (%)0 (0%)0 (0%)0 (0%)0 (0%)
  Negative (%)11 (100.0%)25 (100.0%)15 (100.0%)25 (100.0%)
  P value11